Novel antitumor therapeutic strategy using CD4+ T cell-derived extracellular vesicles.
Shin S, Jung I, Jung D, Kim CS, Kang SM, Ryu S, Choi SJ, Noh S, Jeong J, Lee BY, Park JK, Shin J, Cho H, Heo JI, Jeong Y, Choi SH, Lee SY, Baek MC, Yea K.
Shin S, et al. Among authors: baek mc.
Biomaterials. 2022 Oct;289:121765. doi: 10.1016/j.biomaterials.2022.121765. Epub 2022 Aug 31.
Biomaterials. 2022.
PMID: 36067566